COMPANY PROFILE · /cytoreason
C
CytoReason
AI-powered computational disease modeling platform for pharmaceutical and biotech companies. Uses machine learning to map human diseases and predict drug efficacy, helping accelerate clinical trials and reduce development costs.
Fresh · 3d ago
Latest valuation
—
Annual Recurring Revenue
—
Headcount
120+
Funding total
$180M+
OVERVIEW
Raised $80M (July 2024) from NVIDIA, Pfizer, Thermo Fisher, OurCrowd. 6 of top 10 pharma companies use platform. Partnerships with Pfizer, Roche, Merck for drug discovery.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.